14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.46 $7.67 Wednesday, 24th Apr 2024 BPTH stock ended at $2.49. This is 7.26% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 13.41% from a day low at $2.46 to a day high of $2.79.
90 days $0.352 $7.67
52 weeks $0.320 $7.67

Historical Bio-Path Holdings prices

Date Open High Low Close Volume
Feb 12, 2024 $0.480 $0.480 $0.450 $0.461 39 340
Feb 09, 2024 $0.435 $0.473 $0.411 $0.450 102 455
Feb 08, 2024 $0.460 $0.499 $0.442 $0.450 98 201
Feb 07, 2024 $0.465 $0.490 $0.439 $0.464 132 837
Feb 06, 2024 $0.430 $0.490 $0.414 $0.465 223 226
Feb 05, 2024 $0.420 $0.439 $0.420 $0.430 30 772
Feb 02, 2024 $0.430 $0.450 $0.412 $0.422 42 757
Feb 01, 2024 $0.430 $0.460 $0.430 $0.430 59 414
Jan 31, 2024 $0.411 $0.444 $0.411 $0.411 87 336
Jan 30, 2024 $0.430 $0.473 $0.421 $0.427 51 752
Jan 29, 2024 $0.478 $0.478 $0.422 $0.444 68 846
Jan 26, 2024 $0.455 $0.470 $0.420 $0.470 96 574
Jan 25, 2024 $0.458 $0.469 $0.450 $0.464 56 884
Jan 24, 2024 $0.410 $0.456 $0.400 $0.450 148 490
Jan 23, 2024 $0.440 $0.440 $0.400 $0.411 27 620
Jan 22, 2024 $0.415 $0.437 $0.380 $0.410 64 312
Jan 19, 2024 $0.410 $0.433 $0.400 $0.407 166 057
Jan 18, 2024 $0.435 $0.435 $0.390 $0.420 91 602
Jan 17, 2024 $0.489 $0.489 $0.435 $0.435 20 286
Jan 16, 2024 $0.526 $0.539 $0.460 $0.460 38 437
Jan 12, 2024 $0.509 $0.530 $0.500 $0.500 122 390
Jan 11, 2024 $0.569 $0.579 $0.510 $0.510 90 197
Jan 10, 2024 $0.541 $0.598 $0.541 $0.560 247 900
Jan 09, 2024 $0.533 $0.540 $0.510 $0.530 112 037
Jan 08, 2024 $0.546 $0.546 $0.510 $0.533 63 958
Click to get the best stock tips daily for free!

About Bio-Path Holdings

Bio-Path Holdings Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f... BPTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT